Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe
Clinical trial NCT01389310 · COMPLETED
Trial details
- NCT number
- NCT01389310
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-02-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.